Completed

Automated Caller and Text Message Reminders for Reducing Appointment No-Shows

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Text Message + Automated Caller (Intervention)

Behavioral
Who is being recruted

Over 18 Years
+3 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Other Study

Interventional
Study Start: November 2024
See protocol details

Summary

Principal SponsorM. Kit Delgado, MD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 5, 2024

Actual date on which the first participant was enrolled.

This study is focused on improving the attendance rate of patients at their scheduled outpatient appointments. Penn Medicine has noticed that less than 75% of these appointments are completed, which can cause longer wait times and reduce access to care. To address this, the study is testing if adding an automated phone call to the existing text message reminders can help reduce the number of missed appointments. The target group includes patients who are identified as having a higher risk of not showing up, according to a specific risk model. By finding a more effective reminder method, the study aims to improve appointment completion rates and enhance the efficiency of healthcare operations. During the study, participants are divided into two groups. One group receives the usual text message reminder, while the other gets both the text and an automated phone call. All participants are patients who have already agreed to receive text reminders and have an in-person appointment during the study. The study lasts for two weeks, and throughout this period, researchers track whether patients confirm, cancel, or miss their appointments. The outcomes of this trial will help Penn Medicine decide on the most effective reminder strategy to use in the future, potentially leading to better appointment adherence and healthcare service efficiency.

Official TitleComparative Effectiveness of Targeted Outreach With an Automated Caller for Increasing Appointment Completion: A Randomized Quality Improvement Initiative
NCT06767423
Principal SponsorM. Kit Delgado, MD
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

32925 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Other Study

Some studies explore topics that don't fall into a specific category. These might include innovative research, new technologies, or emerging healthcare areas.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
in-person appointments

English or Spanish speakers

18 years old or older

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Standard text message appointment reminders to English and Spanish-speaking patients. Text reminders will go out 3-weeks, 3 days, and 24 hours before the appointment. If patient has not confirmed their appointment after the 3-week and 3-day reminders, they'll receive an automated caller.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Penn Medicine

Philadelphia, United StatesOpen Penn Medicine in Google Maps
CompletedOne Study Center